Asymchem Revenue and Competitors

TEDA,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Asymchem's estimated annual revenue is currently $143.9M per year.(i)
  • Asymchem's estimated revenue per employee is $201,000

Employee Data

  • Asymchem has 716 Employees.(i)
  • Asymchem grew their employee count by -4% last year.

Asymchem's People

NameTitleEmail/Phone
1
CEO, ChairmanReveal Email/Phone
2
SVPReveal Email/Phone
3
SVP, Process DevelopmentReveal Email/Phone
4
Senior Director Process ChemistryReveal Email/Phone
5
Director Business DevelopmentReveal Email/Phone
6
Senior Director, Process ChemistryReveal Email/Phone
7
Senior Director Process ChemistryReveal Email/Phone
8
Chief Science OfficerReveal Email/Phone
9
Director Business DevelopmentReveal Email/Phone
10
ChemistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Asymchem?

At Asymchem we are proud of the strides that we have made since our founding in 1999, providing R&D and one-stop production services to the world's top pharmaceutical companies. Driving our success is our commitment to continual optimization and investing in the future. By improving the capabilities our partners need now, and maintaining the agility needed to support innovation, we've built a knowledge and experience base that we're ready to share. Our solutions range from early clinical stage to commercial stage, including R&D and cGMP production of advanced intermediates, APIs, formulations, as well as clinical research services. Through strategic partnerships and calculated business growth, we have built an integrated service ecosystem. Our 8 R&D and manufacturing sites are located in P.R. China and are regularly inspected by regulatory bodies such as the USFDA. Our expertise lies in developing and applying innovative technologies such as green chemistry for scaleup of technically complex API's, with the added advantage of in-house raw materials' manufacturing to control availability and lead-times. From initial development of a synthetic chemical process through to manufacturing, Asymchem's proven team of experienced process and engineering teams has th eknowldge to help our clients get things done. Asymchem's toolbox of capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, HPAPI, cryogenic, catalytic hydrogenation, and others.

keywords:N/A

N/A

Total Funding

716

Number of Employees

$143.9M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Asymchem News

2022-04-13 - Expanding API manufacturing operations: Cambrex and ...

Cambrex expands API manufacturing capacity at flagship US facility and Asymchem completes construction of two new Chinese API production...

2022-04-06 - Asymchem completes construction at new Chinese production ...

Chinese CDMO Asymchem Labs completed construction of new production buildings at its Dunhua and Tianjin manufacturing sites in China.

2022-04-06 - Asymchem Completes Construction on Two New Production ...

TEDA TIANJIN, P.R. China, April 6, 2022 /PRNewswire/ -- Asymchem Laboratories (Tianjin) Co., Ltd., a leading CDMO serving the global...